Short Course of Chemo Effective in Early-Stage HER2 Breast Cancer

Combining four cycles of docetaxel and cyclophosphamide with 1 year of trastuzumab may be a viable treatment option for women with HER2-amplified early-stage breast cancer regardless of their TOP2A status, according to the results of a phase II study.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news